Trial Profile
An Open Label, Dose Escalation Study to Assess Intra-Subject Dose Response to VA106483 in Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Fedovapagon (Primary)
- Indications Nocturia
- Focus Pharmacokinetics
- 17 Jul 2012 New trial record